banner
Nucleotide-based Production Service

Nucleotide-based Production Service

Deciphering Nucleotides

Nucleotides are compounds made up of purine/pyrimidine bases, deoxyribose/ribose, and phosphoric acid. There is one phosphate group that exists in nucleoside monophosphate (NMP). The 5'-nucleotide phosphate group can be further phosphorylated to generate nucleoside diphosphate (NDP) and nucleoside triphosphate (NTP), and the phosphate groups are linked by high-energy bonds.

Biological Background of Nucleotides

Nucleotides are the precursors of biological macromolecules DNA, RNA, and participate in the heredity, developmental, and growth activities of organisms as the constituent parts of nucleic acids. In addition, many nucleotides are involved in various important biological functions, such as adenosine triphosphate (ATP), coenzymes, and others related to energy metabolism. Some nucleotide derivatives can interfere with nucleotide metabolism and have broad application prospects as anticancer drugs.

Chemical structures of NMP, NDP, and NTP.Fig.1 Chemical structures of NMP, NDP, and NTP. (CD BioGlyco)

Key Technologies

We deploy integrated chemical and enzymatic methodologies to advance nucleotide synthesis. Our platform synthesizes nucleotides through solution-phase and solid-supported techniques. A pivotal innovation involves single-step condensation reactions that circumvent conventional multi-step synthetic routes. This approach utilizes specialized reagents to construct sugar-nucleotides from commercial precursors with exceptional regioselectivity.

Biocatalytic transformations further expand our capabilities. While typically restricted to natural substrates, our enzymatic processes enable gram-scale nucleotide production. We integrate high-concentration multi-enzyme cascades with selective precipitation purification, a chromatography-free strategy optimized for industrial-scale throughput. This synergistic fusion of chemical precision and enzymatic efficiency empowers us to tackle diverse nucleoside analogs and synthetically challenging targets.

Scale with Precision: Nucleotides Perfected

In the spirit of quality first, service first, CD BioGlyco is committed to producing various high-purity nucleotides for customers. We have NMP, NDP, and NTP production services, as well as nucleotide derivative production services according to your specific needs.

There is one phosphate group in the NMP molecule. Guanosine monophosphate (GMP) has a taste property, with the ability to be a condiment. Milk powder is rich in NMP, which plays a role in improving the immunomodulatory capacity and memory of infants. We deliver end-to-end synthesis of NMPs, combining enzymatic precision with scalable processes:

NDP is obtained by adding a high-energy bonded phosphate group to NMP. ADP is a component of Coenzyme I/II. UDP is mainly used as an activated intermediate, such as UDP-glucose and CDP-ethanolamine.

NTP with three phosphate groups in the molecule is the universal energy currency. ATP is the most common; UTP functions in glycogen synthesis, CTP provides energy in phospholipid synthesis, and GTP plays a role in protein synthesis.

Nucleotide derivatives are of great value in various fields. Their powerful therapeutic effects have been shown in diseases such as cancer, cardiovascular disease, inflammation, and viral infection. In addition, they also have extensive and stable nutritional and health care functions.

Workflow

  • Substrate Preparation

Prepare nucleoside and sugar substrates by dissolving them in appropriate buffers (e.g., phosphate buffer) at optimal concentrations, ensuring purity through filtration or chromatography if necessary.

  • Enzyme Selection and Activation

Select specific glycosyltransferases or nucleotidyltransferases (depending on the target nucleoside-sugar) and activate them by reconstituting in a buffer with cofactors to initiate catalytic activity.

  • Reaction Mixture Setup

Combine the prepared nucleoside, sugar, activated enzyme, and cofactors in a reaction vessel, adjusting pH and temperature to match the enzyme's optimal conditions.

  • Incubation and Monitoring

Incubate the mixture under controlled conditions to allow the enzymatic reaction, where the sugar moiety is transferred to the nucleoside. Monitor progress periodically using analytical techniques to track product formation.

  • Reaction Termination

Stop the reaction once the desired yield is achieved by methods such as heat inactivation, adding denaturing agents, or adjusting pH to extremes.

  • Purification of Product

Separate the nucleoside-sugar product from unreacted substrates, enzymes, and by-products using purification steps like column chromatography, solvent extraction, or precipitation.

  • Characterization and Quantification

Confirm the identity and purity of the purified nucleoside-sugar using spectroscopic methods and quantify the yield via HPLC with a standard curve or UV-visible spectroscopy.

Our workflow. (CD BioGlyco)

Publication Data

DOI.: 10.1021/acssynbio.3c00737

Journal: ACS Synthetic Biology

IF: 3.9

Published: 2024

Results: This review details advances in engineering nucleotide sugar metabolism in Saccharomyces cerevisiae to enable glycosylation of natural products. The authors propound methodologies broadening yeast's endogenous UDP-sugar repertoire, constrained strictly to UDP-glucose and UDP-galactose, through salvage avenues (exploiting exogenous sugars) and de novo routes (wherein existing nucleotides undergo enzymatic interconversions). Key challenges include overcoming feedback inhibition mechanisms (e.g., UDP-xylose suppressing UDP-glucuronic acid synthesis) and engineering promiscuous glycosyltransferases. Successful applications include producing glycosylated terpenoids (e.g., saponins, steviol glycosides) and flavonoids (e.g., scutellarin) by expressing heterologous enzymes. The work highlights yeast's potential as a chassis for synthesizing bioactive glycosides with therapeutic value.

Application

  • Nucleotide analogues are widely used in the development of antiviral and anticancer drugs.
  • Sugar-nucleotides are crucial intermediates for studying carbohydrate metabolism and glycoconjugate biosynthesis. They are also used as substrates for enzymatic reactions in carbohydrate synthesis.
  • Naturally occurring and modified sugar-nucleotides can be used as potent enzyme inhibitors in new therapeutic research.

Advantage

  • Our platform is designed for scalability, from small-scale research quantities to gram-scale production for clinical development.
  • We offer a vast library of natural sugar-nucleotides and can synthesize a wide variety of structural analogues.
  • Our expertise in handling both chemical and enzymatic synthesis allows us to create highly customized products to meet your specific and unique project requirements.

Frequently Asked Questions

Associated Services

Our nucleotide production delivers high-purity nucleotides tailored for therapeutic and diagnostic research. To extend their functional utility, we offer Phosphate Group-based Modification Services that engineer stability, reactivity, and targeting properties:

CD BioGlyco provides Custom Carbohydrate Synthesis services and exclusive solutions for clients. If you are interested in our nucleotide-based production service or Glyco™ Synthesis Platform, please feel free to contact us for more information.

Reference

  1. Crowe, S.A.; et al. Advances in engineering nucleotide sugar metabolism for natural product glycosylation in Saccharomyces cerevisiae. ACS Synthetic Biology. 2024, 13(6): 1589-1599. (Open Access)
This service is for Research Use Only, not intended for any clinical use.
Quick Links
Resources

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0